NCT05242952

Brief Summary

The investigator is testing a virtual environment to address prevention of HIV-related comorbidities.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P25-P50 for not_applicable cardiovascular-diseases

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 28, 2020

Completed
1.3 years until next milestone

First Posted

Study publicly available on registry

February 16, 2022

Completed
1.2 years until next milestone

Study Start

First participant enrolled

May 10, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2025

Completed
Last Updated

July 28, 2025

Status Verified

July 1, 2025

Enrollment Period

1.9 years

First QC Date

October 28, 2020

Last Update Submit

July 25, 2025

Conditions

Keywords

ComorbidityCardiovascular DiseasesSexual and Gender MinoritiesHIV InfectionsVirtual RealityCardiovascular Health

Outcome Measures

Primary Outcomes (1)

  • Acceptability/Feasibility {change over 3 timepoints}

    Based on Technology Acceptance Model, using the same unit of measure, we will examine Perceived Usefulness (Cronbach's alpha 0.98) and Perceived Ease of Use (Cronbach's alpha 0.94) with an online 7-point Likert scale.

    Baseline and Month 3 & 6

Secondary Outcomes (6)

  • Cardiovascular health {change over 3 timepoints}

    Baseline and Month 3 & 6

  • Physical Activity {change over 3 timepoints}

    Baseline and Month 3 & 6

  • Tobacco and E-cigarette use {change over 3 timepoints}

    Baseline and Month 3 & 6

  • Food consumption {change over 3 timepoints}

    Baseline and Month 3 & 6

  • Psychosocial wellbeing {change over 3 timepoints}

    Baseline and Month 3 & 6

  • +1 more secondary outcomes

Study Arms (2)

Immediate Intervention Group

EXPERIMENTAL

Participants will enter an online game and learn about how to prevent cardiovascular and metabolic conditions.

Behavioral: Gaming in a virtual environment

Waitlist Control Group

OTHER

Participants will enter an online game at a later date after the immediate intervention group and learn about how to prevent cardiovascular and metabolic conditions.

Behavioral: Gaming in a virtual environment

Interventions

To address the primary outcomes of feasibility and acceptability of the VE, we will capture process data using a computer-based virtual environment and self-report measures using an online survey.

Immediate Intervention GroupWaitlist Control Group

Eligibility Criteria

Age30 Years - 65 Years
Sexmale(Gender-based eligibility)
Gender Eligibility Detailsassigned male sex at birth
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • identify as an ethnic/racial minority with HIV
  • identify as gay, same-gender-loving, or MSM
  • able to read and understand English
  • access to a computer capable of downloading and running the VE software
  • no medical history of serious cardiovascular or cognitive complications

You may not qualify if:

  • myocardial infarction (MI)
  • congestive heart failure (CHF)
  • coronary artery bypass graft (CABG)
  • cerebral vascular accident (CVA)
  • cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yale University

Orange, Connecticut, 06477, United States

Location

Related Publications (4)

  • Ramos SR, Warren R, Shedlin M, Melkus G, Kershaw T, Vorderstrasse A. A Framework for Using eHealth Interventions to Overcome Medical Mistrust Among Sexual Minority Men of Color Living with Chronic Conditions. Behav Med. 2019 Apr-Jun;45(2):166-176. doi: 10.1080/08964289.2019.1570074.

    PMID: 31343963BACKGROUND
  • Ramos SR, O'Hare OM, Hernandez Colon A, Kaplan Jacobs S, Campbell B, Kershaw T, Vorderstrasse A, Reynolds HR. Purely Behavioral: A Scoping Review of Nonpharmacological Behavioral and Lifestyle Interventions to Prevent Cardiovascular Disease in Persons Living With HIV. J Assoc Nurses AIDS Care. 2021 Sep-Oct 01;32(5):536-547. doi: 10.1097/JNC.0000000000000230.

    PMID: 33481464BACKGROUND
  • Ramos SR, Johnson C, Melkus G, Kershaw T, Gwadz M, Reynolds H, Vorderstrasse A. Cardiovascular Disease Prevention Education Using a Virtual Environment in Sexual-Minority Men of Color With HIV: Protocol for a Sequential, Mixed Method, Waitlist Randomized Controlled Trial. JMIR Res Protoc. 2022 May 17;11(5):e38348. doi: 10.2196/38348.

    PMID: 35579928BACKGROUND
  • Ramos SR, Reynolds H, Johnson C, Melkus G, Kershaw T, Thayer JF, Vorderstrasse A. Perceptions of HIV-Related Comorbidities and Usability of a Virtual Environment for Cardiovascular Disease Prevention Education in Sexual Minority Men With HIV: Formative Phases of a Pilot Randomized Controlled Trial. J Med Internet Res. 2024 Aug 22;26:e57351. doi: 10.2196/57351.

MeSH Terms

Conditions

Cardiovascular DiseasesCoitusHIV Infections

Condition Hierarchy (Ancestors)

Sexual BehaviorBehaviorBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • S. Raquel Ramos, PhD, MBA, MSN, FNP-BC

    Yale University School of Nursing

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 28, 2020

First Posted

February 16, 2022

Study Start

May 10, 2023

Primary Completion

March 31, 2025

Study Completion

March 31, 2025

Last Updated

July 28, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations